Labcorp Expands Regional Laboratory in Raritan, New Jersey
Expansion strengthens diagnostic capabilities, enhances operational efficiency and supports broader patient access across the Northeast
BURLINGTON, N.C. (February 3, 2025) – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its laboratory in Raritan, New Jersey. The facility expansion will significantly enhance Labcorp’s capabilities to provide best-in-class experiences for the patients, healthcare providers and local communities it serves across the Northeast region.
“This expansion reinforces Labcorp’s role as a trusted healthcare partner in the Northeast and beyond,” said Bill Haas, senior vice president of Labcorp’s Northeast Division. “We are well-positioned to meet growing demand and deliver fast, high-quality results to patients and healthcare providers across the region.”
The expansion adds 110,000 square feet of advanced laboratory space and a state-of-the-art warehouse and logistics hub, further strengthening Labcorp’s position as a leader in diagnostic testing and healthcare innovation. With over 1,300 laboratory professionals working at the Raritan site, the laboratory processes specimens from more than 110,000 patients daily.
“The innovative advancements throughout our Raritan facility strengthen our ability to provide faster, more reliable testing while driving new insights that support our mission to improve health and improve lives,” said Mark Schroeder, executive vice president and president of Diagnostics and chief operations officer for Labcorp. “By investing in advanced technology and infrastructure, we’re positioning Labcorp to scale operations to best serve the company’s growing demand and enhancing patient care by supporting healthcare providers with the reliable diagnostics they need to make informed healthcare decisions.”
With a network of nearly 170 patient service centers across New Jersey, Labcorp is committed to providing patients with greater convenience and access to high-quality diagnostics. Through its growing collaborations with leading large and regional health systems and federally qualified health centers, Labcorp continues to expand the reach of essential testing, enabling communities across the Northeast to benefit from industry-leading laboratory services.
For more information about Labcorp’s services and innovations, visit www.labcorp.com.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.